Germline mutations in BRCA1 and BRCA2 are the two main genes predisposing to early development of breast and ovarian tumors; they account for the majority of cases in families with high‐risk profiles, representing a 26% to 84% lifetime risk for those cancers (Malone et al. This evidence concerns the gene BRCA2 and cancer.